ID   RIMB2_HUMAN             Reviewed;        1052 AA.
AC   O15034; Q96ID2;
DT   16-JAN-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-JUN-2009, sequence version 3.
DT   18-JUN-2025, entry version 186.
DE   RecName: Full=RIMS-binding protein 2;
DE            Short=RIM-BP2;
GN   Name=RIMBP2; Synonyms=KIAA0318, RBP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9205841; DOI=10.1093/dnares/4.2.141;
RA   Nagase T., Ishikawa K., Nakajima D., Ohira M., Seki N., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VII. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 4:141-150(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Fetal kidney;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   STRUCTURE BY NMR OF 158-244; 477-593 AND 839-1017.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the SH3 domains and FNIII domain of KIAA0318
RT   protein.";
RL   Submitted (NOV-2005) to the PDB data bank.
CC   -!- FUNCTION: Plays a role in the synaptic transmission as bifunctional
CC       linker that interacts simultaneously with RIMS1, RIMS2, CACNA1D and
CC       CACNA1B. {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with RIMS1, RIMS2, CACNA1D and CACNA1B, and
CC       potentially with other Ca(2+) channel alpha-1 isoforms. {ECO:0000250}.
CC   -!- INTERACTION:
CC       O15034-2; P41227: NAA10; NbExp=3; IntAct=EBI-12906594, EBI-747693;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}. Synapse
CC       {ECO:0000250}. Note=Synaptic plasma membrane. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O15034-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O15034-2; Sequence=VSP_009212, VSP_009214, VSP_009215;
CC       Name=3;
CC         IsoId=O15034-3; Sequence=VSP_009213, VSP_009216;
CC   -!- DOMAIN: The SH3 domains mediate binding to a proline-rich motif in
CC       RIMS1, RIMS2, CACNA1D and CACNA1B. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the RIMBP family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA20776.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB002316; BAA20776.1; ALT_INIT; mRNA.
DR   EMBL; BX641152; CAE46066.1; -; mRNA.
DR   EMBL; AC063926; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC007632; AAH07632.1; -; mRNA.
DR   CCDS; CCDS31925.1; -. [O15034-1]
DR   RefSeq; NP_001338162.1; NM_001351233.2. [O15034-2]
DR   RefSeq; NP_056162.4; NM_015347.4. [O15034-1]
DR   PDB; 1WIE; NMR; -; A=160-242.
DR   PDB; 2CSI; NMR; -; A=955-1017.
DR   PDB; 2CSP; NMR; -; A=477-593.
DR   PDB; 2CSQ; NMR; -; A=841-924.
DR   PDBsum; 1WIE; -.
DR   PDBsum; 2CSI; -.
DR   PDBsum; 2CSP; -.
DR   PDBsum; 2CSQ; -.
DR   AlphaFoldDB; O15034; -.
DR   BMRB; O15034; -.
DR   SMR; O15034; -.
DR   BioGRID; 117051; 8.
DR   FunCoup; O15034; 232.
DR   IntAct; O15034; 6.
DR   STRING; 9606.ENSP00000261655; -.
DR   GlyCosmos; O15034; 3 sites, 1 glycan.
DR   GlyGen; O15034; 4 sites, 1 O-linked glycan (3 sites).
DR   iPTMnet; O15034; -.
DR   PhosphoSitePlus; O15034; -.
DR   BioMuta; RIMBP2; -.
DR   jPOST; O15034; -.
DR   MassIVE; O15034; -.
DR   PaxDb; 9606-ENSP00000261655; -.
DR   PeptideAtlas; O15034; -.
DR   ProteomicsDB; 48391; -. [O15034-1]
DR   ProteomicsDB; 48392; -. [O15034-2]
DR   ProteomicsDB; 48393; -. [O15034-3]
DR   ABCD; O15034; 3 sequenced antibodies.
DR   Antibodypedia; 65349; 46 antibodies from 13 providers.
DR   DNASU; 23504; -.
DR   Ensembl; ENST00000261655.8; ENSP00000261655.4; ENSG00000060709.17. [O15034-1]
DR   GeneID; 23504; -.
DR   KEGG; hsa:23504; -.
DR   UCSC; uc001uil.3; human. [O15034-1]
DR   AGR; HGNC:30339; -.
DR   CTD; 23504; -.
DR   DisGeNET; 23504; -.
DR   GeneCards; RIMBP2; -.
DR   HGNC; HGNC:30339; RIMBP2.
DR   HPA; ENSG00000060709; Tissue enhanced (brain, parathyroid gland, pituitary gland).
DR   MIM; 611602; gene.
DR   OpenTargets; ENSG00000060709; -.
DR   VEuPathDB; HostDB:ENSG00000060709; -.
DR   eggNOG; KOG3632; Eukaryota.
DR   GeneTree; ENSGT00950000183203; -.
DR   HOGENOM; CLU_001979_0_0_1; -.
DR   InParanoid; O15034; -.
DR   OrthoDB; 4158657at2759; -.
DR   PAN-GO; O15034; 1 GO annotation based on evolutionary models.
DR   PhylomeDB; O15034; -.
DR   PathwayCommons; O15034; -.
DR   SignaLink; O15034; -.
DR   SIGNOR; O15034; -.
DR   BioGRID-ORCS; 23504; 12 hits in 1148 CRISPR screens.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; RIMBP2; human.
DR   EvolutionaryTrace; O15034; -.
DR   GenomeRNAi; 23504; -.
DR   Pharos; O15034; Tdark.
DR   PRO; PR:O15034; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; O15034; protein.
DR   Bgee; ENSG00000060709; Expressed in Brodmann (1909) area 10 and 146 other cell types or tissues.
DR   ExpressionAtlas; O15034; baseline and differential.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; IEA:UniProtKB-SubCell.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IBA:GO_Central.
DR   CDD; cd00063; FN3; 3.
DR   CDD; cd12014; SH3_RIM-BP_1; 1.
DR   CDD; cd12012; SH3_RIM-BP_2; 1.
DR   CDD; cd12013; SH3_RIM-BP_3; 1.
DR   FunFam; 2.30.30.40:FF:000023; RIMS-binding protein 2 isoform F; 1.
DR   FunFam; 2.30.30.40:FF:000006; RIMS-binding protein 2 isoform X1; 1.
DR   FunFam; 2.60.40.10:FF:000072; RIMS-binding protein 2 isoform X1; 1.
DR   FunFam; 2.60.40.10:FF:000643; RIMS-binding protein 2 isoform X1; 1.
DR   FunFam; 2.30.30.40:FF:000016; RIMS-binding protein 2 isoform X2; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 3.
DR   Gene3D; 2.30.30.40; SH3 Domains; 3.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR035753; RIM-BP_SH3_2.
DR   InterPro; IPR035755; RIM-BP_SH3_3.
DR   InterPro; IPR040325; RIMBP1/2/3.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR14234; RIM BINDING PROTEIN-RELATED; 1.
DR   PANTHER; PTHR14234:SF18; RIMS-BINDING PROTEIN 2; 1.
DR   Pfam; PF00041; fn3; 1.
DR   Pfam; PF07653; SH3_2; 2.
DR   Pfam; PF14604; SH3_9; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00060; FN3; 3.
DR   SMART; SM00326; SH3; 3.
DR   SUPFAM; SSF49265; Fibronectin type III; 2.
DR   SUPFAM; SSF50044; SH3-domain; 3.
DR   PROSITE; PS50853; FN3; 3.
DR   PROSITE; PS50002; SH3; 3.
DR   neXtProt; NX_O15034; -.
DR   PharmGKB; PA143485594; -.
DR   TreeFam; TF316230; -.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Membrane;
KW   Phosphoprotein; Proteomics identification; Reference proteome; Repeat;
KW   SH3 domain; Synapse.
FT   CHAIN           1..1052
FT                   /note="RIMS-binding protein 2"
FT                   /id="PRO_0000221383"
FT   DOMAIN          167..234
FT                   /note="SH3 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          297..390
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          393..475
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          489..590
FT                   /note="Fibronectin type-III 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          848..916
FT                   /note="SH3 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          952..1019
FT                   /note="SH3 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   REGION          115..164
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          584..615
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          629..666
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          697..716
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          767..787
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          805..829
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1029..1052
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        146..156
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        585..598
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        645..654
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1040..1052
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         704
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JIR1"
FT   MOD_RES         712
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JIR1"
FT   MOD_RES         832
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80U40"
FT   MOD_RES         839
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80U40"
FT   MOD_RES         841
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80U40"
FT   VAR_SEQ         1..863
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_009213"
FT   VAR_SEQ         1..92
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_009212"
FT   VAR_SEQ         735..737
FT                   /note="PHC -> MVS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_009214"
FT   VAR_SEQ         738..1052
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_009215"
FT   VAR_SEQ         1045..1052
FT                   /note="KKSVHFTP -> VSKPI (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_009216"
FT   VARIANT         593
FT                   /note="P -> R (in dbSNP:rs2292664)"
FT                   /id="VAR_057714"
FT   VARIANT         888
FT                   /note="D -> N (in dbSNP:rs11060869)"
FT                   /id="VAR_057715"
FT   CONFLICT        1051
FT                   /note="T -> I (in Ref. 1; BAA20776)"
FT                   /evidence="ECO:0000305"
FT   TURN            164..166
FT                   /evidence="ECO:0007829|PDB:1WIE"
FT   STRAND          169..176
FT                   /evidence="ECO:0007829|PDB:1WIE"
FT   HELIX           180..182
FT                   /evidence="ECO:0007829|PDB:1WIE"
FT   TURN            188..190
FT                   /evidence="ECO:0007829|PDB:1WIE"
FT   STRAND          199..205
FT                   /evidence="ECO:0007829|PDB:1WIE"
FT   STRAND          208..210
FT                   /evidence="ECO:0007829|PDB:1WIE"
FT   STRAND          213..216
FT                   /evidence="ECO:0007829|PDB:1WIE"
FT   STRAND          228..230
FT                   /evidence="ECO:0007829|PDB:1WIE"
FT   STRAND          491..495
FT                   /evidence="ECO:0007829|PDB:2CSP"
FT   STRAND          503..509
FT                   /evidence="ECO:0007829|PDB:2CSP"
FT   STRAND          519..522
FT                   /evidence="ECO:0007829|PDB:2CSP"
FT   STRAND          524..539
FT                   /evidence="ECO:0007829|PDB:2CSP"
FT   STRAND          545..551
FT                   /evidence="ECO:0007829|PDB:2CSP"
FT   HELIX           552..557
FT                   /evidence="ECO:0007829|PDB:2CSP"
FT   STRAND          562..570
FT                   /evidence="ECO:0007829|PDB:2CSP"
FT   HELIX           583..586
FT                   /evidence="ECO:0007829|PDB:2CSP"
FT   STRAND          851..854
FT                   /evidence="ECO:0007829|PDB:2CSQ"
FT   TURN            861..863
FT                   /evidence="ECO:0007829|PDB:2CSQ"
FT   STRAND          864..866
FT                   /evidence="ECO:0007829|PDB:2CSQ"
FT   HELIX           868..871
FT                   /evidence="ECO:0007829|PDB:2CSQ"
FT   STRAND          882..889
FT                   /evidence="ECO:0007829|PDB:2CSQ"
FT   STRAND          894..899
FT                   /evidence="ECO:0007829|PDB:2CSQ"
FT   STRAND          902..907
FT                   /evidence="ECO:0007829|PDB:2CSQ"
FT   TURN            908..910
FT                   /evidence="ECO:0007829|PDB:2CSQ"
FT   STRAND          911..913
FT                   /evidence="ECO:0007829|PDB:2CSQ"
FT   STRAND          954..958
FT                   /evidence="ECO:0007829|PDB:2CSI"
FT   TURN            965..967
FT                   /evidence="ECO:0007829|PDB:2CSI"
FT   STRAND          971..973
FT                   /evidence="ECO:0007829|PDB:2CSI"
FT   TURN            974..976
FT                   /evidence="ECO:0007829|PDB:2CSI"
FT   STRAND          985..991
FT                   /evidence="ECO:0007829|PDB:2CSI"
FT   STRAND          994..1002
FT                   /evidence="ECO:0007829|PDB:2CSI"
FT   STRAND          1005..1010
FT                   /evidence="ECO:0007829|PDB:2CSI"
FT   HELIX           1011..1013
FT                   /evidence="ECO:0007829|PDB:2CSI"
SQ   SEQUENCE   1052 AA;  116026 MW;  065FADD690A7A8BC CRC64;
     MREAAERRQQ LQLEHDQALA VLSAKQQEID LLQKSKVREL EEKCRTQSEQ FNLLSRDLEK
     FRQHAGKIDL LGGSAVAPLD ISTAPSKPFP QFMNGLATSL GKGQESAIGG SSAIGEYIRP
     LPQPGDRPEP LSAKPTFLSR SGSARCRSES DMENERNSNT SKQRYSGKVH LCVARYSYNP
     FDGPNENPEA ELPLTAGKYL YVYGDMDEDG FYEGELLDGQ RGLVPSNFVD FVQDNESRLA
     STLGNEQDQN FINHSGIGLE GEHILDLHSP THIDAGITDN SAGTLDVNID DIGEDIVPYP
     RKITLIKQLA KSVIVGWEPP AVPPGWGTVS SYNVLVDKET RMNLTLGSRT KALIEKLNMA
     ACTYRISVQC VTSRGSSDEL QCTLLVGKDV VVAPSHLRVD NITQISAQLS WLPTNSNYSH
     VIFLNEEEFD IVKAARYKYQ FFNLRPNMAY KVKVLAKPHQ MPWQLPLEQR EKKEAFVEFS
     TLPAGPPAPP QDVTVQAGVT PATIRVSWRP PVLTPTGLSN GANVTGYGVY AKGQRVAEVI
     FPTADSTAVE LVRLRSLEAK GVTVRTLSAQ GESVDSAVAA VPPELLVPPT PHPRPAPQSK
     PLASSGVPET KDEHLGPHAR MDEAWEQSRA PGPVHGHMLE PPVGPGRRSP SPSRILPQPQ
     GTPVSTTVAK AMAREAAQRV AESSRLEKRS VFLERSSAGQ YAASDEEDAY DSPDFKRRGA
     SVDDFLKGSE LGKQPHCCHG DEYHTESSRG SDLSDIMEED EEELYSEMQL EDGGRRRPSG
     TSHNALKILG NPASAGRVDH MGRRFPRGSA GPQRSRPVTV PSIDDYGRDR LSPDFYEESE
     TDPGAEELPA RIFVALFDYD PLTMSPNPDA AEEELPFKEG QIIKVYGDKD ADGFYRGETC
     ARLGLIPCNM VSEIQADDEE MMDQLLRQGF LPLNTPVEKI ERSRRSGRRH SVSTRRMVAL
     YDYDPRESSP NVDVEAELTF CTGDIITVFG EIDEDGFYYG ELNGQKGLVP SNFLEEVPDD
     VEVYLSDAPS HYSQDTPMRS KAKRKKSVHF TP
//
